| For: |
Sun B, Li ZS, Tu ZX, Xu GM, Du YQ. Construction of an oral recombinant DNA vaccine from |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i43/7042.htm |
| Number | Citing Articles |
| 1 |
Masoud Keikha, Majid Eslami, Bahman Yousefi, Abdolmajid Ghasemian, Mohsen Karbalaei. Potential antigen candidates for subunit vaccine development against Helicobacter pylori infection. Journal of Cellular Physiology 2019; 234(12) doi: 10.1002/jcp.28870
|
| 2 |
Marina de Bernard, Mario M. D'Elios. The immune modulating activity of the Helicobacter pylori HP-NAP: Friend or foe?. Toxicon 2010; 56(7) doi: 10.1016/j.toxicon.2009.09.020
|
| 3 |
Zhili Liu, He Li, Xiaotian Huang, Qiong Liu. Advances and challenges in Helicobacter pylori subunit vaccine development: antigen candidates and immunization strategies. Journal of Applied Microbiology 2025; 136(10) doi: 10.1093/jambio/lxaf236
|
| 4 |
Nasrin Mirzaei, Farkhondeh Poursina, Sharareh Moghim, Niloufar Rashidi, Hajieh Ghasemian Safaei. The study ofH. pyloriputative candidate factors for single- and multi-component vaccine development. Critical Reviews in Microbiology 2017; 43(5) doi: 10.1080/1040841X.2017.1291578
|
| 5 |
Kanishtha Agarwal, Shvetank Agarwal. Helicobacter pylori Vaccine: From Past to Future. Mayo Clinic Proceedings 2008; 83(2) doi: 10.4065/83.2.169
|
| 6 |
Francesca Vallese, Nigam M. Mishra, Matteo Pagliari, Paola Berto, Gaia Codolo, Marina de Bernard, Giuseppe Zanotti. Helicobacter pylori antigenic Lpp20 is a structural homologue of Tipα and promotes epithelial-mesenchymal transition. Biochimica et Biophysica Acta (BBA) - General Subjects 2017; 1861(12) doi: 10.1016/j.bbagen.2017.09.017
|
| 7 |
Mario Milco D’Elios, Leif P. Andersen. Helicobacter pylori Inflammation, Immunity, and Vaccines. Helicobacter 2007; 12(s1) doi: 10.1111/j.1523-5378.2007.00530.x
|
| 8 |
Mariana Ingolotti, Omkar Kawalekar, Devon J Shedlock, Karuppiah Muthumani, David B Weiner. DNA vaccines for targeting bacterial infections. Expert Review of Vaccines 2010; 9(7) doi: 10.1586/erv.10.57
|
| 9 |
Kanishtha Agarwal, Shvetank Agarwal. Helicobacter pylori Vaccine: From Past to Future. Mayo Clinic Proceedings 2008; 83(2) doi: 10.1016/S0025-6196(11)60838-0
|
| 10 |
Xueyong Huang, Bianli Xu, Guangcai Duan, Chunhua Song. The rOmp22–HpaA Fusion Protein Confers Protective Immunity Against Helicobacter pylori in Mice. Current Microbiology 2013; 67(4) doi: 10.1007/s00284-013-0390-x
|
| 11 |
Armita Balash, Abbas Doosti. Study on the immunogenicity of pcDNA3.1(+)-cagT recombinant vector against Helicobacter pylori in BALB/c mice. Journal of Shahrekord University of Medical Sciences 2020; 22(4) doi: 10.34172/jsums.2020.26
|
| 12 |
Xiaoyan Peng, Rongguang Zhang, Guangcai Duan, Chen Wang, Nan Sun, Linghan Zhang, Shuaiyin Chen, Qingtang Fan, Yuanlin Xi. Production and delivery of Helicobacter pylori NapA in Lactococcus lactis and its protective efficacy and immune modulatory activity. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-24879-x
|
| 13 |
Tiruvayipati Suma Avasthi, Niyaz Ahmed.
Helicobacter pylori
and Type 1 Diabetes Mellitus: Possibility of Modifying Chronic Disease Susceptibility with Vaccinomics at the Anvil
. OMICS: A Journal of Integrative Biology 2011; 15(9) doi: 10.1089/omi.2010.0138
|
| 14 |
Elena Alexander. Yeasts in nanotechnology-enabled oral vaccine and gene delivery. Bioengineered 2021; 12(1) doi: 10.1080/21655979.2021.1985816
|
| 15 |
Katayoun Borhani, Ashraf Mohabati Mobarez, Ali Reza Khabiri, Mehrdad Behmanesh, Nima Khoramabadi. Inhibitory effects of rHP-NAP IgY against Helicobacter pylori attachment to AGS cell line. Microbial Pathogenesis 2016; 97 doi: 10.1016/j.micpath.2016.06.004
|